EagleTribune.com, North Andover, MA

World/National News

June 1, 2014

New drugs may make a dent in some cancer

CHICAGO (AP) — New drugs are making a dent against some hard-to-treat cancers, but some results raise fresh questions about whether the benefit is worth the cost. For the first time in a decade, an experimental drug has extended the lives of patients with advanced lung cancer who relapsed after standard chemotherapy. But the drug used in the study gave patients just six extra weeks of life on average, and costs $6,000 per infusion as currently sold to treat a different form of cancer.

Eli Lilly and Co.’s drug, Cryamza, was discussed Saturday at a cancer conference in Chicago, where other studies showed:

n The drug Imbruvica, sold by Pharmacyclics Inc. and Janssen Biotech, substantially improved survival and could set a new standard of care for relapsed chronic lymphocytic leukemia, or CLL, the most common leukemia in adults. Doctors say the pill more precisely targets cancer and is a good option for older people who can’t tolerate standard chemotherapy infusions.

n Two experimental pills from AstraZeneca PLC worked much better than one alone against ovarian cancer that resisted or came back after standard chemo. The drugs significantly prolonged the time women lived without their disease worsening.

LUNG CANCER

Cyramza is sold now to treat stomach cancer and fights the formation of blood vessels that feed tumors. French researchers led a study with 1,253 patients who relapsed after initial treatment of advanced lung cancer, a more common disease.

All were given the chemo drug docetaxel and half also received Cyramza infusions every three weeks. Median overall survival was 10.5 months for those on the combo and 9 months for the others; there were significantly more side effects with the combo.

“I don’t think a six-week increment is that impressive” for survival, said Dr. Derek Raghavan, an independent expert and president of the Levine Cancer Institute at Carolinas HealthCare System in Charlotte, North Carolina. He also is on a task force on value in cancer care for the American Society of Clinical Oncology, the group hosting the conference.

Text Only | Photo Reprints
Latest News
World/National News

Latest U.S. News
3 People Killed, Deputies Wounded in NC Shootout Suing Obama: GOP-led House Gives the Go-ahead Obama: 'Blood of Africa Runs Through My Veins' Amid Drought, UCLA Sees Only Water Texas Scientists Study Ebola Virus Smartphone Powered Paper Plane Debuts at Airshow Air Force: Stowaway Triggers Security Review Minnesota Fire Engulfs Home, Two Garages Southern Accent Reduction Class Cancelled in TN Obama Chides House GOP for Pursuing Lawsuit New Bill Aims to Curb Sexual Assault on Campus 3Doodler Bring 3-D Printing to Your Hand Six PA Cops Indicted for Robbing Drug Dealers Officials Unsure of UCLA Flood Repair Date At Least 20 Chikungunya Cases in New Jersey Raw: Obama Eats Ribs in Kansas City Broken Water Main Floods UCLA Raw: Japanese Soldiers Storm Beach in Exercises In Virginia, the Rise of a New Space Coast Two Women Narrowly Avoid Being Hit by Train
Latest World News
Raw: 16 Killed in Gaza Market Strike Raw: Guinea Rap Concert Stampede Kills 33+ Raw: Deadly Landslide Hits Indian Village Graphic Video: 15 Killed at Gaza UN School Russia Counts Cost of New US, EU Sanctions Britain Testing Driverless Cars on Roadways Raw: Floodwaters Ravage Villages in Romania Raw: Thousands Flocking to German Crop Circle Raw: Otters Enjoy Water Slides at Japan Zoo Raw: Japanese Soldiers Storm Beach in Exercises Raw: Weapons Fire Hits UN School in Gaza Raw: Rocket Launches Into Space With Cargo Ship Today in History for July 30th Raw: Aftermath, Artillery Shells Hit Donetsk Muslims Celebrate Eid El-Fitr Around the World Gaza Official: at Least 100 Killed Tuesday Kerry: Not Worried About Israeli Criticism US Ready to Slap New Sanctions on Russia Rodents Rampant in Gardens Around Louvre Raw: Earthquake Rocks Mexico's Gulf Coast
Photos of the Week